Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114
CDX-6114 meets safety and tolerability endpoints REDWOOD CITY, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a […]
Sorrento Therapeutics Closes Five-Year Term Loan Financing for Up to $150 Million
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a clinical-stage immunotherapy biotech company, announces the […]
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of […]
Merus to Present at the Jefferies 2018 London Healthcare Conference
UTRECHT, The Netherlands, Nov. 08, 2018 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody […]
Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
ALPHARETTA, Ga., Nov. 08, 2018 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments […]
Akoustis to Attend the 4th Annual Roth Technology Corporate Access Day on November 14, 2018
Charlotte, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented bulk […]
Recro Pharma to Participate in Upcoming Investor Conferences
MALVERN, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on […]
Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update
ELX-02 has been granted an orphan drug designation by the European Medicines Agency (EMA) for Cystic Fibrosis Advancing several investigational […]
Trevena Reports Third Quarter 2018 Financial Results and Announces Workforce Restructuring
– $70.0 Million of Cash, Cash Equivalents and Marketable Securities as of September 30, 2018 – – Company to host […]
TSX News -
Intertape Polymer Group Reports 2018 Third Quarter Results
Quarterly revenue increased 14.6% to $279.1 million Quarterly IPG Net Earnings decreased $7.2 million to $12.0 million Quarterly IPG Adjusted […]
